People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Athenen Therapeutics, Inc. | — | Pharmaceuticals | Series A | $12.0M | $371.7M | 2019 |
| Arcuate Therapeutics, Inc. | — | Pharmaceuticals | Series A | $5.0M | $154.9M | 2019 |
Aaron Bergener at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Aaron Bergener on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ANDREW LEVIN | 2 | 17 |
| Joshua Resnick | 2 | 12 |
| James Schneider | 2 | 5 |
| Sarah Reed | 2 | 2 |
| Adam Rosenberg | 1 | 6 |
| Sari Epstein | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.